THE COMPLEXITIES OF HEART FAILURE: Novel Approaches for Management of Resistant Heart Failure



Registration Statement


By clicking the Registration Button below you are agreeing that you have read and understood the CME Statements below.


Registration

  VenueCityStateDate
View Agenda  The Broadmoor Colorado SpringsCO Sunday
Oct 11, 2015 9:00 AM
View Agenda  Yosemite Lodge at the FallsYosemite National ParkCA Monday
Oct 19, 2015 12:00 AM
View Agenda  Heart HouseWashingtonDC Saturday
Nov 21, 2015 12:00 AM
View Agenda  The Ritz-Carlton Lodge, Reynolds PlantationGreensboroGA Sunday
Nov 22, 2015 11:00 AM


Presentation Slides


Download (PDF) Click here to view the presentation slides and transcript from this CME-certified series held at select American College of Cardiology state chapter meetings.

PROGRAM OVERVIEW

Over the years, heart failure (HF) has been described in the context of a number of different theoretic models that capture a variety of perspectives of the disease process. Representative examples include the hemodynamic model, which envisions HF as compromised heart-pump capacity; the cardio-renal model, which views HF as a consequence of volume overload and compromised renal function; the neurohumoral model, which describes HF as hyperactivity of the sympathetic nervous system and vasopressor mechanisms that overwhelm vasodilator/natriuretic mechanisms; and the abnormal calcium cycling model, which focuses on metabolic stressors or genetic anomalies that lead to abnormal stimulus-contraction coupling of the cardiomyocyte. All of these models have provided insights about new pharmacologic targets for the management of HF, many of which are entering late-stage clinical development.

THE COMPLEXITIES OF HEART FAILURE: Novel Approaches for Management of Resistant Heart Failure will provide participants with a better understanding of the difference in pathophysiologic mechanisms between HF with preserved ejection fraction (HFpEF) and HF with reduced ejection fraction (HFrEF). Participants will be better able to incorporate evidence-based guidelines and results from large outcomes studies into clinical practice to decrease morbidity and mortality in patients with HF. They will also better understand newer therapeutic targets involved in the pathophysiology of HF, and emerging therapeutic agents that interact with these targets.

Faculty


Mark E. Dunlap, MD
Director, Heart Failure Section
Heart and Vascular Center, The MetroHealth System
Professor of Medicine, Physiology, and Biophysics
Case Western Reserve University
Cleveland, OH

Read Biography 

James E. Udelson, MD
Chief, Division of Cardiology
Tufts Medical Center
Professor of Medicine and Radiology
Tufts University School of Medicine
Boston, MA

 Read Biography

Richard Allen Williams, MD, FACC, FAHA
Clinical Professor of Medicine
UCLA School of Medicine
President/CEO
Minority Health Institute, Inc.
Los Angeles, CA

Read Biography

Target Audience


This program is intended for community cardiologists, interventional cardiologists, primary care physicians, and other professionals who treat patients with heart failure.


Educational Objectives

At the conclusion of this activity, participants should be able to demonstrate the ability to:
  • Identify current therapies for patients with both reduced and preserved ejection fraction heart failure, as well as for patients of diverse ethnicities
  • Analyze mechanisms of action and different clinical attributes of approved therapies and those in clinical development for the management of heart failure
  • List therapies under development that have the potential to improve overall outcomes in those with heart failure
  • Adopt quality-improvement strategies, such as education and engagement, to involve patients more in the management and monitoring of their disease

Accreditation

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The Potomac Center for Medical Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity. 


For questions regarding CME credit or the evaluation, please email contact@potomacme.org

Disclosure Information

Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.

All persons in a position to control the content of a continuing medical education program provided by PCME are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts of interest are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners.

The content of this activity was vetted by an external medical reviewer to assure objectivity and that the activity is free of commercial bias.


FDA Disclosure

The contents of some CME activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.

Method of Participation

To complete the activity and receive credit, the participant must attend the program and complete the evaluation form. A CME certificate will be emailed 2 weeks after submission of a completed evaluation form.

There is no fee associated with this program.

SPECIAL SERVICES


 Event staff will be glad to assist you with any specials needs.  Please email specialservices@rockpointe-pcme.com at least 5 days prior to the program.

Jointly PROVIDED By


Jointly provided by
     
     


     

Supported By


This activity has been supported by an educational grant from Amgen

Registration Statement


By clicking the Registration Button below you are agreeing that you have read and understood the CME/CE Statements above.

Registration is for planning purposes only. Seating is limited and will be provided on a first-come, first-served basis.



Registration

  VenueCityStateDate
View Agenda  The Broadmoor Colorado SpringsCO Sunday
Oct 11, 2015 9:00 AM
View Agenda  Yosemite Lodge at the FallsYosemite National ParkCA Monday
Oct 19, 2015 12:00 AM
View Agenda  Heart HouseWashingtonDC Saturday
Nov 21, 2015 12:00 AM
View Agenda  The Ritz-Carlton Lodge, Reynolds PlantationGreensboroGA Sunday
Nov 22, 2015 11:00 AM